Kidney rules exempt oral meds from Amgen, Genzyme - FiercePharma PDF Print
FiercePharmaThere's a silver lining in new Medicare rules for dialysis patients for Amgen (NASDAQ: AMGN), which stands to lose a big chunk of sales of its IV anemia

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.

Notice: Undefined variable: query in /home/globaldi/public_html/components/com_joomlawatch/class.joomlawatch.db.php on line 129